Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial-Reference-Cited by-同舟云学术

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

Published:2015-09 Issue:9 Volume:16 Page:1037-1048
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bear Harry D,Tang Gong,Rastogi Priya,Geyer Charles E,Liu Qing,Robidoux André,Baez-Diaz Luis,Brufsky Adam M,Mehta Rita S,Fehrenbacher Louis,Young James A,Senecal Francis M,Gaur Rakesh,Margolese Richard G,Adams Paul T,Gross Howard M,Costantino Joseph P,Paik Soonmyung,Swain Sandra M,Mamounas Eleftherios P,Wolmark Norman

Funder

National Institute of Health (NIH)

Publisher

Elsevier BV

Subject

Oncology

Reference52 articles.

1. Bevacizumab added to neoadjuvant chemotherapy for breast cancer;Bear;N Engl J Med,2012

2. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol,1997

3. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

4. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer;Gianni;J Clin Oncol,2009

5. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-27;Bear;J Clin Oncol,2003

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis;BMC Cancer;2024-04-09

2. Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials;Journal of Cancer Research and Clinical Oncology;2024-01

3. The diagnostic approach and management of hypertension in the emergency department;European Journal of Internal Medicine;2023-12

4. Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities;International Journal of Molecular Sciences;2023-11-26

5. Based polymer nanoparticles from bee pollen attenuate non-small lung cancer through enhancement of apoptosis and cell cycle arrest in vivo;Cancer Nanotechnology;2023-10-06